Tag: NFL301
NFL BIOSCIENCES: FILING OF A PRE-IND APPLICATION WITH THE FDA IN THE UNITED STATES FOR NFL-301 DEDICATED TO THE REDUCTION OF ALCOHOL CONSUMPTION – 12/19/2023 at 08:00
NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical drugs for the treatment of dependencies and addictions, announces that it has today filed a pre-IND…
NFL Biosciences soars on the stock market after a co-development agreement for its drug candidate NFL-301
The biopharmaceutical company announces a co-development agreement for its drug candidate NFL-301, intended to reduce alcohol consumption. NFL Biosciences takes off on the stock market after a co-development agreement for…
NFL Biosciences collaborates with Athena Pharmaceuticals for its drug candidate NFL-301
Subscribe for 1€ Unlimited access to all advice More than 800 stocks listed in Paris and abroad screened. To buy ? To sell ? What course objective? Our experts engage…